TGFBI was originally identified as a downstream effector of the TGF-β signaling pathway, a key network governing cell proliferation, differentiation, apoptosis, and migration, and playing a key role in tumor suppression in lymphoid cells [56,57,58]. The gene discussed is TGFB1; the disease is neoplasm.